Since the coronavirus disease (COVID-19) pandemic hit the globe in early 2020, we have
steadily gained insight into its pathogenesis; thereby improving surveillance and preventive …

Multisystem inflammatory disease in neonates (MIS-N) is a disease of immune dysregulation
presenting in the newborn period. Thouvgh its etiopathogenesis is proposed to be similar to …

Starting in late 2019, a novel coronavirus rapidly spread throughout the world, resulting in a
global pandemic. The virus was designated severe acute respiratory syndrome coronavirus …

OBJECTIVE Although the US infant mortality rate reached a record low in 2020, the sudden
infant death syndrome (SIDS) rate increased from 2019. To understand if the increase was …

Infants aged< 1 year represent a seemingly more susceptible pediatric subset for infections.
Despite this, coronavirus disease 2019 (COVID-19) infection has not been proven as more …

Objective Characterize the prevalence of coronavirus disease 2019 (COVID-19) diagnosis
among mothers with infants hospitalized in 294 neonatal intensive care units (NICUs), and …

The COVID-19 pandemic has had a profound impact on global health, with neonates
emerging as a uniquely vulnerable population. This chapter provides a condensed yet …

Adults and children exhibit a broad range of clinical outcomes from SARS-CoV-2 infection,
with minimal to mild symptoms, especially in the pediatric age. However, some children …

Despite the substantial body of investigative work describing the Coronavirus Disease 2019
(COVID-19) pandemic, its impact on neonates and infants remains less well characterized …

Objective Coronavirus disease 2019 (COVID-19) generally causes milder illness in the
pediatric population. However, infants represent a higher-risk population with evolving …